Advanced Targeted Radiofluorescence & Therapy
Forging our goal of self-guided surgeries
WE LIGHT UP CANCER
At Antelope Surgical Solutions, we make tumors glow
Our patented small molecules bind to cancer cells and light them up — revealing invisible margins in real time.Surgeons see exactly where to cut, and where to stop.For the first time, precision is visible — during the operation, not afterward.
01
Multimodality Radioligand Theranostic Novel Drug For Disease Management
At Antelope Surgical Solutions, Inc., we are driven by our passion for developing cutting-edge products that will revolutionize the medical biotechnology industry. Since our founding in 2020, we’ve established a GMP manufacturing facility equipped with robotic high-throughput synthesis capabilities and received our first FDA IND clearance for our lead agent. Our innovative multimodal small molecule, designed for diagnostic, radiotherapeutic, and fluorescence-guided surgical applications, is built upon our patent pending, first-of-its-kind chemical syntheses. With a team of experts, we are committed to inspiring and leading with our groundbreaking ideas and expertise.
02
Tenets
01
In Vivo Identification
Definitive in vivo identification of tumors and metastases during surgery with additional imagining agents to enhance surgical precision.
02
GMP Synthesis
Antelope Surgical's current pipeline includes two imaging agents, with plans to expand and introduce more in the future.
03
Proprietary Solutions
We aim to have the first multimodality radioligand therapeutic and fluorescent agent approved by the US Food and Drug Administration on the market.
“The future of surgery is
AI-guided.
Surgeon-led.
Antelope-powered.”
Dr. Amy Wu
03
ANTELOPE'S PIPELINE
03
OUR PARTNERS
03
OUR PARTNERS
